APICES Acknowledged for its Remarkable Role in GEOCP-SEOR Study

APICES CRO is pleased to announce its contribution to the GEOCP-SEOR study. This is a RWE Study in Non Small Cell Lung Cancer (NSCLC), recently featured in the Cancers Journal.

The study evaluates and provide real-world insights into the management of non-small cell lung cancer stage III (NSCLC-SIII) in Spain.

APICES contributed to the study through medical editorial assistance. The work of Fernando Rico-Villademoros, and Juan Luis Sanz, along with the broader Spanish team, has been instrumental in the success of this project.

We also acknowledge AstraZeneca Spain and Paloma Sosa Fajardo for the collaboration and opportunity to contribute to this important study advancing treatment options in oncology.

For further information about the GEOCP-SEOR Study, please read the full scientific publication following the link: Stage III NSCLC Treatment Patterns in Spain: A Population-Based Study of the GOECP-SEOR